New Zealand markets closed

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
36.03+0.30 (+0.84%)
At close: 04:00PM EDT
36.10 +0.07 (+0.19%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 76.42B
Enterprise value 95.22B
Trailing P/E 13.93
Forward P/E 11.31
PEG ratio (5-yr expected) 1.67
Price/sales (ttm)1.73
Price/book (mrq)3.94
Enterprise value/revenue 2.56
Enterprise value/EBITDA 9.59

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 3-16.02%
S&P500 52-week change 3-4.45%
52-week high 347.89
52-week low 332.96
50-day moving average 341.90
200-day moving average 343.81

Share statistics

Avg vol (3-month) 36.18M
Avg vol (10-day) 39.23M
Shares outstanding 52.03B
Implied shares outstanding 6N/A
Float 81.96B
% held by insiders 10.03%
% held by institutions 112.90%
Shares short (28 Jul 2022) 46.12M
Short ratio (28 Jul 2022) 41.49
Short % of float (28 Jul 2022) 4N/A
Short % of shares outstanding (28 Jul 2022) 40.30%
Shares short (prior month 29 Jun 2022) 46.69M

Dividends & splits

Forward annual dividend rate 42.48
Forward annual dividend yield 46.90%
Trailing annual dividend rate 30.86
Trailing annual dividend yield 32.42%
5-year average dividend yield 45.25
Payout ratio 481.99%
Dividend date 305 Oct 2022
Ex-dividend date 418 May 2022
Last split factor 21226:1000
Last split date 321 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 12.24%
Operating margin (ttm)23.48%

Management effectiveness

Return on assets (ttm)6.58%
Return on equity (ttm)24.71%

Income statement

Revenue (ttm)37.24B
Revenue per share (ttm)18.56
Quarterly revenue growth (yoy)18.70%
Gross profit (ttm)22.66B
Net income avi to common (ttm)4.57B
Diluted EPS (ttm)2.78
Quarterly earnings growth (yoy)-39.90%

Balance sheet

Total cash (mrq)6.53B
Total cash per share (mrq)3.24
Total debt (mrq)22.11B
Total debt/equity (mrq)97.67
Current ratio (mrq)1.43
Book value per share (mrq)8.13

Cash flow statement

Operating cash flow (ttm)10.51B
Levered free cash flow (ttm)-9.89B